This work covers new findings on hypertrophic cardiomyopathy. The definition, genetic findings, genotype-phenotype relationships, incidence, and prognosis of the disease are reviewed. The latest recommendations for treatment are discussed, particularly percutaneous transluminal septal myocardial ablation and septal myectomy in severely symptomatic obstructive forms.

• Keywords
• hypertrofie myokardu, léčba hypertrofických kardiomyopatií, perkutánní septální ablace, septální myektomie,
• MeSH
• Adrenergic beta-Antagonists therapeutic use   MeSH
• Calcium Channel Blockers therapeutic use   MeSH
• Echocardiography methods   utilization   MeSH
• Electrocardiography methods   utilization   MeSH
• Drug Therapy methods   standards   utilization   MeSH
• Financing, Organized MeSH
• Genetic Markers genetics   MeSH
• Cardiomyopathy, Hypertrophic * diagnosis   classification   therapy   MeSH
• Angiotensin-Converting Enzyme Inhibitors therapeutic use   MeSH
• Cardiac Surgical Procedures methods   trends   utilization   MeSH
• Cardiomegaly diagnosis   genetics   classification   MeSH
• Catheter Ablation methods   trends   MeSH
• Humans MeSH
• International Classification of Diseases history   classification   utilization   MeSH
• Prognosis MeSH
• Cardiac Catheterization methods   utilization   MeSH
• Heart Septum surgery   pathology   MeSH
• Statistics as Topic MeSH
• Check Tag
• Humans MeSH
• Publication type
• Review MeSH

• MeSH
• Acromegaly classification   complications   ultrastructure   MeSH
• Adult MeSH
• Echocardiography methods   instrumentation   statistics & numerical data   MeSH
• Hypertrophy MeSH
• Cardiomegaly etiology   classification   ultrastructure   MeSH
• Humans MeSH
• Prospective Studies MeSH
• Aged MeSH
• Check Tag
• Adult MeSH
• Humans MeSH
• Male MeSH
• Aged MeSH
• Female MeSH
• Publication type
• Comparative Study MeSH

• MeSH
• Cardiomegaly classification   MeSH
• Humans MeSH
• Check Tag
• Humans MeSH